Submitted by Anonymous (not verified) on 26 February 2026 - 14:15
Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 45, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Remsima, infliximab, Date of authorisation: 10/09/2013, Revision: 45, Status: Authorised